Seyed Mohammad Abedi Selected Research

tricine

1/2020	99m Tc-(EDDA/tricine)-HYNIC-GnRH analogue as a potential imaging probe for diagnosis of prostate cancer.
1/2020	Evaluation of a New <sup>99m</sup>Tc-labeled GnRH Analogue as a Possible Imaging Agent for Prostate Cancer Detection.
8/2018	Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer.
2/2018	99mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.
1/2018	An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor.
1/2018	99m Tc-HYNIC-(Ser)3 -J18 peptide: A radiotracer for non-small-cell lung cancer targeting.
8/2017	Biological Evaluation of 99mTc-HYNIC-EDDA/tricine-(Ser)-D4 Peptide for Tumor Targeting.
1/2017	Comparative assessment of a 99mTc labeled H1299.2-HYNIC peptide bearing two different co-ligands for tumor-targeted imaging.
2/2014	An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seyed Mohammad Abedi Research Topics

Disease

28	Neoplasms (Cancer) 11/2022 - 09/2012
7	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 09/2012
5	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2018 - 04/2017
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016 - 01/2014
2	COVID-19 01/2022 - 11/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2020
1	Febrile Neutropenia 01/2022
1	Ductal Carcinoma 04/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Infections 11/2020
1	Cough 11/2020
1	Fever (Fevers) 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2020
1	Glioma (Gliomas) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Carcinogenesis 01/2020
1	Cardiotoxicity 11/2018
1	Colonic Neoplasms (Colon Cancer) 07/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Necrosis 01/2018
1	Adenocarcinoma 01/2018
1	Cicatrix (Scar) 12/2017
1	Pyelonephritis 12/2017
1	Urinary Tract Infections (Urinary Tract Infection) 12/2017
1	Adenocarcinoma of Lung 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Xerostomia 01/2014

Drug/Important Bio-Agent (IBA)

17	Peptides (Polypeptides)IBA 11/2022 - 01/2017
9	tricineIBA 01/2020 - 02/2014
8	EDDA (NiEDDA)IBA 01/2020 - 02/2014
5	LigandsIBA 01/2021 - 02/2014
5	RadiopharmaceuticalsIBA 02/2018 - 09/2012
3	Radioisotopes (Radionuclides)IBA 11/2022 - 11/2013
3	Biological ProductsIBA 01/2021 - 04/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 01/2018
2	human ERBB2 proteinIBA 01/2020 - 02/2017
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2018 - 09/2012
2	leucyl- threonyl- valyl- seryl- prolyl- tryptophyl- tyrosineIBA 01/2018 - 02/2017
2	peptide AIBA 01/2018 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2017
2	Nucleotide AptamersIBA 02/2014 - 11/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2021
1	methylene diphosphonateIBA 04/2021
1	phenylpiperazineIBA 01/2021
1	Pimozide (Orap)FDA Link 01/2021
1	Febuxostat FDA Link 11/2020
1	C-Reactive ProteinIBA 11/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2020
1	Trastuzumab (Herceptin)FDA Link 05/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	ResveratrolIBA 11/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 07/2018
1	PeptidomimeticsIBA 07/2018
1	NeurotensinIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2018
1	Succimer (Dimercaptosuccinic Acid)FDA Link 12/2017
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Tissue Inhibitor of Metalloproteinase-1IBA 12/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2017
1	GE11 peptideIBA 05/2017
1	Chelating AgentsIBA 02/2017
1	Serine (L-Serine)FDA Link 02/2017
1	Single-Domain AntibodiesIBA 01/2017
1	ThymolIBA 01/2016
1	Radiation-Protective Agents (Radiation Protectants)IBA 09/2015
1	Vitamin E FDA LinkGeneric 09/2015
1	OligonucleotidesIBA 01/2015
1	NucleolinIBA 01/2015
1	AGRO 100IBA 01/2015
1	GuanineIBA 01/2015
1	Propolis (Bee Bread)IBA 01/2014
1	Bevacizumab (Avastin)FDA Link 09/2012
1	Monoclonal AntibodiesIBA 09/2012
1	Iodine-131IBA 09/2012

Therapy/Procedure

8	Therapeutics 11/2022 - 09/2015
3	Drug Therapy (Chemotherapy) 11/2022 - 01/2018
2	Radiotherapy 08/2021 - 01/2014
2	Gamma Cameras (Gamma Camera) 01/2018 - 01/2018
1	Personal Protective Equipment 01/2022
1	Contraindications 11/2020
1	Radioimmunotherapy 09/2012